CLINICAL_TRIALS ClinicalTrials.gov record update

A Multi-center Study of hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse Post Definitive Surgery and Standard Therapy

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02960594
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:05.430901+00:00
Published At: 2018-11-19T00:00:00+00:00
Record Updated At: 2018-11-19
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Breast Cancer", "Lung Cancer", "Pancreatic Cancer", "Head and Neck Cancer", "Ovarian Cancer", "ColoRectal Cancer", "Gastric Cancer", "Esophageal Cancer", "HepatoCellular Carcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-11-19"
protocolSection.identificationModule.nctId: "NCT02960594"
protocolSection.identificationModule.officialTitle: "A Multi-center Study of hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse Post Definitive Surgery and Standard Therapy"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.